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Abstract
Background: As schizophrenia is genetically and phenotypically heterogeneous, targeting genetically informative
phenotypes may help identify greater linkage signals. The aim of the study is to evaluate the genetic linkage evidence
for schizophrenia in subsets of families with earlier age at onset or greater neurocognitive deficits.
Methods: Patients with schizophrenia (n = 1,207) and their first-degree relatives (n = 1,035) from 557 families with
schizophrenia were recruited from six data collection field research centers throughout Taiwan. Subjects completed a face-
to-face semi-structured interview, the Continuous Performance Test (CPT), the Wisconsin Card Sorting Test, and were
genotyped with 386 microsatellite markers across the genome.
Results: A maximum nonparametric logarithm of odds (LOD) score of 4.17 at 2q22.1 was found in 295 families ranked by
increasing age at onset, which had significant increases in the maximum LOD score compared with those obtained in initial
linkage analyses using all available families. Based on this subset, a further subsetting by false alarm rate on the undegraded
and degraded CPT obtained further increase in the nested subset-based LOD on 2q22.1, with a score of 7.36 in 228 families
and 7.71 in 243 families, respectively.
Conclusion: We found possible evidence of linkage on chromosome 2q22.1 in families of schizophrenia patients with more
CPT false alarm rates nested within the families with younger age at onset. These results highlight the importance of
incorporating genetically informative phenotypes in unraveling the complex genetics of schizophrenia.
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Introduction
Family and twin studies have indicated that schizophrenia has a
strong genetic basis [1]. However, previous genetic linkage and
association studies have not conclusively detected susceptibility loci
and genetic variants for schizophrenia [2,3]. Heterogeneity in the
etiology of schizophrenia may partly account for the conflicting
results. Further, the current diagnostic schemes may not capture
the most heritable features of schizophrenia. To overcome these
obstacles, using genetically informative phenotypes has been
advocated since this may reduce heterogeneity or represent the
more direct effects of underlying susceptibility genes [4].
Conceptually, a genetically informative phenotype can be a
component phenotype, i.e., a symptom or dimension which is a
component of the disorder itself found only in affected individuals,
or an intermediate phenotype, i.e., a quantitative phenotype which
is found in both affected individuals and their nonpsychotic
relatives.
Cumulative evidence suggests that age at onset is one potential
component phenotype for schizophrenia. Compared with schizo-
phrenia patients with late onset, those with early age at onset have
been associated with more severe cognitive impairments and
poorer outcomes [5]. In addition, patients with an early onset were
more likely to have relatives affected with schizophrenia [6], and a
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e24103greater correlation in age at onset was found in affected
monozygotic twin pairs than in dizygotic twin pairs [7].
Meanwhile, neurocognitive deficits such as sustained attention
deficit and executive dysfunction are possible intermediate
phenotypes for schizophrenia. Sustained attention deficits as
measured on the Continuous Performance Test (CPT) [8] are
present, not only in schizophrenia patients, but also in subjects
with schizotypal personality disorder and in nonpsychotic relatives
of schizophrenia patients [9]. Family studies have found an
elevated recurrence risk ratio for CPT deficits among nonpsy-
chotic parents or siblings [10] and a positive association between
the severity of the CPT deficits and the familial loading for
schizophrenia [11]. The performance deficits in schizophrenia
patients are stable in clinical course and not amenable to
treatment with neuroleptics [12]. Executive functioning as
measured by the Wisconsin Card Sorting Test (WCST) [13] have
also been found to be impaired in schizophrenia patients [14] and
their first degree relatives [15], though the magnitude of familial
aggregation is modest at best [16].
A number of candidate gene studies have explored the relations
of certain genetic variants to schizophrenia by subgrouping
patients using these genetically informative phenotypes of
schizophrenia, including age at onset [17], and differential
impairments on the CPT or WCST [18]. However, the
subgrouping in these studies was mainly based on a predetermined
cut-off, which may not result in the most homogenous subsets. An
attractive alternative for exploring susceptibility loci influencing
different informative phenotypes of schizophrenia is a discovery-
based genome-wide scan such as ordered subset analysis (OSA), a
method not requiring a priori specification of the subset [19].
Given that age at onset is only partially associated with the severity
of neurocognitive deficits in schizophrenia [20], subsetting families
using a combination of these phenotypes may help further reveal a
more homogeneous subset of families with greater linkage signals.
This study aimed to evaluate the genetic linkage evidence for
empirically derived subtypes of schizophrenia by applying ordered
subset linkage analyses in a large sample of families of siblings co-
affected with schizophrenia, which consisted mainly of a single
ethnic group [21]. We hypothesized that using a homogeneous
subtype of schizophrenia on the basis of age at onset or
neurocognitive deficits can help obtain increased linkage signals
as well as identify additional regions as compared with the initial
genome-wide linkage scan of schizophrenia.
Methods
Subjects and clinical evaluation
Participants of this study included patients with schizophrenia
and their first-degree relatives recruited from six data collection
research center throughout the nation in the Taiwan Schizophrenia
Linkage Study between 1998 and 2002. The study design,
ascertainment process, and sample characteristics have been
described in more detail elsewhere [22]. In brief, the large nation-
wide sample of schizophrenia families were ascertained on the basis
ofsib-pairsco-affected withDSM-IVschizophrenia,whichincluded
only families of Han Chinese ancestry. The original linkage sample
consisted of 1,207 affected individuals (57 parents and 1,150
siblings) and 1,035 unaffected individuals (764 parents and 828
siblings) from 557 schizophrenia families [23]. All subjects provided
written informed consent after the study procedures were explained
to them. Best-estimate final diagnoses were made by two board-
certified research psychiatrists independently on the basis of all
clinical information, including the Diagnostic Interview for Genetic
Studies (DIGS) [24], the Family Interview for Genetic Studies
(FIGS) [25], hospital records, and the interviewer’s notes. The study
was approved by both the US Department of Health and Human
Services and the National Taiwan University Hospital’s Internal
Review Board of Human Studies.
The DIGS includes a psychosis section that inquires about the
age at onset of the first psychotic episode that could not be
attributed to medical illness, medications, or substance abuse.
When the information with regard to onset of the first psychotic
episode on the interview was unclear, research psychiatrists would
review the medical history and determine the age at onset.
Neurocognitive assessment
Probands and their relatives completed both the CPT and the
WCST. The degraded and undegraded version of CPT -‘1-9’
procedure has been described in detail elsewhere [26]. Briefly,
numbers from 0 to 9 were randomly presented for 50 msec each, at a
rate of one per second. Each subject undertook two CPT -‘1-9’
sessions: the undegraded 1-9 tasks and 25% degraded 1-9 tasks.
Sensitivity (d’), derived from the hit rate (probability of response to
target trials) and false alarm rate (probability of response to nontarget
trials), reflects an individual’s ability to discriminate target stimuli from
nontarget ones. In addition, the reaction time (i.e., the mean time to
respond correctly) for each session was also used for the analyses.
For the WCST, we used a computerized version [27]. Subjects
were required to match response cards to the four stimulus cards
along one of three dimensions (color, form, or number) by pressing
one of the 1 to 4 number keys on the computer keyboard. Subjects
were not informed of the correct sorting principle, nor were they
told when the principle would shift during the test, but they were
given feedback (‘‘Right’’ or ‘‘Wrong’’) on the screen after each
trial. The testing continued until all 128 cards were sorted. Eight
performance indices as described in the WCST manual [28] were
used for subsequent analyses: Total Errors, Nonperseverative
Errors, Perseverative Errors, Perseverative Responses, Categories
Achieved, Trials to Complete First Category, Conceptual Level
Response, and Failure to Maintain Set.
The adjusted z scores of the CPT indices were derived by means
of standardizing the raw scores with adjustments for sex, age, and
education against a community sample of 345 individuals [26],
while adjusted z scores of the WCST with adjustments for sex, age,
and education derived for individual against another group of 440
healthy controls [29]. Because some adjusted z scores were
extremely small (,25) or large (.5), these scores were winsorized
as 25 or 5, respectively.
Genotyping
The original genotyping was conducted by the Center for
Inherited Disease Research, with 386 markers spaced at an
average of 9-cM intervals, following the center’s standard
genotyping procedures (http://www.cidr.jhmi.edu). A series of
procedures for quality control was adopted for the genotyping,
such as duplicate assays with a discordancy rate of 0.06%, and
checking for non-Mendelian inheritance and pedigree inconsis-
tencies with an overall rate of 0.39% in genotype and family errors
[21]. Erroneous genotypes were removed accordingly. Marker
distances were generated by using the sex-averaged Marshfield
genetic map. The data included for this study were collected
through NIMH’s genetic initiative for schizophrenia and details
about how to access these data can be found at the following
website: http://zork.wustl.edu/nimh.
Statistical analysis
Ordered subset linkage analyses. Based on the original
sample of genome-wide linkage analysis for schizophrenia, a series
A Linkage Scan for Subsets of Schizophrenia
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odds (LOD) scores by means of Kong and Cox linear model in
affected pedigree members [30] derived from software Merlin [31]
as input. The method ranks each family by a family-level value of a
disease-related covariate of interest and identifies the contiguous
subset of families that maximize the evidence for linkage.
In this study, a series of family’s covariates was explored,
including the average values of the age at onset, CPT scores, and
WCST scores from affected siblings. The whole procedures are
depicted in the upper part of Figure 1. Of the original 557
families, 556 families had information on age at onset, 509 families
on undegraded CPT scores, 499 families on degraded CPT scores,
and 444 families on WCST scores, respectively. At the beginning
of OSA, all the families were ranked according to the magnitude of
a chosen family covariate, with those having the same covariate
given the same rank. The genome-wide linkage analysis was then
conducted in a series of subsets incrementally, starting with the
rank that had the greatest family covariate. The procedure was
repeated until all families were included in the final subset.
Since earlier age at onset as well as greater CPT-related or
WCST-related deficits were associated with greater familial
loading for schizophrenia, the following indices were ranked using
ascending order: age at onset, four CPT indices (i.e., hit rate and
d9 on both undegraded and degraded task), and three WCST
indices (i.e., Categories Achieved, Conceptual Level Response,
and Failure to Maintain Set). Meanwhile, the remaining indices
were ranked using the descending order: four CPT indices (i.e.,
false alarm rate and reaction time on both undegraded and
degraded task) and five WCST indices (i.e., Total Errors, Non-
perseverative Errors, Perseverative Errors, Perseverative Respons-
es, Trials to Complete First Category).
Chromosome-wide significance. The statistical signifi-
cance of the difference between the greatest LOD scores in a
subset of families identified by the OSA and the LOD scores at the
same position in the full set of families was evaluated via 1,000
permutations. Under the null hypothesis that the ranking of the
covariate is independent of the family’s LOD scores on the target
chromosome, the families were randomly permuted with respect
to the covariate ranking and a chromosome-wide p value for each
chromosome was yielded. A P value of # 0.05 was considered
significant, suggesting that a particular subset of individuals in the
sample is more strongly linked to the specified chromosomal
region than the whole sample. The procedures are summarized in
the left part of Figure 2.
Nested ordered subset linkage analysis. Because OSA-
derived subsets of families might have tied covariates, we
attempted to introduce another subphenotype to further dissect
the families (right part of Figure 1). In an OSA-derived subset of
families characterized by a covariate that resulted in the greatest
LOD scores, the families were further re-ranked by means of
another subphenotype. The nested OSA procedure was repeated
to seek a nested subset of families that resulted in a further increase
in the linkage signal on the particular chromosome than the
original subset. A P value of ,0.05 in permutation was considered
significant.
Genome-wide significance. After the permutation on the
composition of a subset of families, which provides chromosome-
wide significance level, we further evaluated its genome-wide
significance by simulating the genotype data of the families and
then estimating the empirical significance level with correction for
multiple phenotypes, as illustrated in the right part of Figure 2.
First, the genome-wide significance level of a subset-based
maximum LOD score was derived from 1,000 simulations in
our genotype data generated by the gene-dropping algorithm in
Merlin. Simulated data were based on our original family
structure, marker informativeness, spacing, and missing status,
with phenotypic measurement and affection status being
preserved. An ad hoc correction procedure was performed to
account for the multiple informative phenotypes used in this study.
For the OSA part, there were 17 covariates examined (including
age at onset and 16 indices on the CPT and the WCST), and thus
the threshold of a corrected genome-wide significance level was set
as 0.0029 (i.e., 0.05/17). For the nested OSA part, there were 33
covariates examined (17 covariates in the OSA and 16 indices on
Figure 1. Flow chart of the ordered subset analysis (OSA) and nested OSA of genetic linkage in 557 families of siblings co-affected
with schizophrenia. CPT, Continuous Performance Test; WCST, Wisconsin Card Sorting Test; LOD, logarithm of odds.
doi:10.1371/journal.pone.0024103.g001
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genome-wide significance level was set as 0.0015 (i.e., 0.05/33).
Second, according to the Lander and Kruglyak threshold [32],
which was also derived from simulations, a LOD score of greater
than 3.6 indicates attaining genome-wide significance. To
maintain the overall genome-wide significance level after consid-
ering multiple informative phenotypes used in this study, an ad hoc
correction procedure was also performed, which was calculated as
LOD(corrected) = 3.6 + log10 (numbers of tests) [33]. Accordingly,
the threshold of a LOD score reaching genome-wide significance
was raised to 4.8 for the OSA part, and to 5.1 for the nested OSA
part.
Family covariates comparison. The family covariate
values between the subset of families that resulted in the greatest
linkage signals and the remaining families were then compared. A
linear mixed effect model with family treated as a random effect
was applied using the Proc MIXED of the SAS software version
9.1 (SAS Institute, Cary, NC, USA) to adjust for within-family
correlation.
Results
The distributions of individual covariates, which were averaged
over the affected siblings of each family, are listed in Table 1.O n
the basis of the adjusted z scores, the affected siblings had poorer
performance across all of the indices that were based on the
correctness of the response on both the CPT and WCST in
comparison with the normative data. Meanwhile, the affected
siblings had longer reaction time on both the undegraded and
degraded CPT than the community norm. Furthermore, the
measures of age at onset and neurocognitive performances
employed in this study demonstrated significant familial resem-
blance, with an affected sib-pair correlation of 0.29 for age at onset
(P,0.0001), 0.14 to 0.31 for CPT indices (P ranging from 0.004 to
0.0001), and 0.12 to 0.24 for WCST indices (P ranging from 0.04
to 0.0001).
Table 2 summarizes the results of OSA that had a significant
increase (empirical P # 0.05) in a subset-based maximum LOD
score from the initial LOD scores of the whole sample. The results
of the OSA identified distinct chromosomal regions implicated for
schizophrenia with different informative phenotypes: 1) 2q22.1 for
younger age at onset; 2) 7q32.2, 8q13.1, and 9q34 for greater
undegraded CPT-related deficits; 3) 7q32.3 for greater degraded
CPT-related deficits; and 4) 8q13.1 and 8q21.1 for greater
WCST-related deficits. For the five loci with significant increases
in subset-based LOD scores, the percentage of linked families in
each subset ranged from 10% to 53% of the whole sample. When
the families within the subset were compared with the remaining
families for the corresponding subphenotype, there were indeed
significant differences between the two groups in the covariates,
with earlier age at onset or more neurocognitive deficits in the
subset of families. Of those covariate/locus combinations with a
Figure 2. Flow chart of the estimation of chromosome-wide significance (left panel) and genome-wide significance (right panel) for
a maximum subset-based logarithm of odds (LOD) in the ordered subset analysis (OSA) and nested OSA of genetic linkage in 557
families of siblings co-affected with schizophrenia.
doi:10.1371/journal.pone.0024103.g002
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reached genome-wide significance based on simulations after an ad
hoc correction for multiple informative phenotypes, whereas no
locus reached the Lander and Kruglyak genome-wide significance
threshold after an ad hoc correction for multiple informative
phenotypes.
Among the loci identified in Table 2, the greatest LOD scores
of 4.17 at D2S442 (147 cM) was found in 53% of the families (n =
295, mean age at onset = 18.70) ranked by age at onset. Since
many of the families had the same mean values of age at onset, we
were interested in whether a further subsetting by one CPT or
WCST index could result in further increase in the LOD score on
the same chromosomal region. Before the subsetting, we examined
the relations of age at onset to either a CPT or WCST index and
found no significant correlations in any of them (data not shown).
As displayed in Table 3, among these CPT-related and WCST-
related deficits, only undegraded and degraded CPT false alarm
rate reached significant increase in the nested OSA-based LOD on
2q22.1, with a score of 7.36 (empirical P=0.004) in 81% of 282
families (mean adjusted z scores of false alarm rate = 1.84, mean
age at onset =18.40) and 7.71 (empirical P=0.001) in 87% of 281
families (mean adjusted z scores of false alarm rate = 1.49, mean
age at onset =18.40), respectively. Of note, both the LOD score of
7.36 (nominal P,0.00001) and of 7.71 (nominal P,0.00001)
reached genome-wide significance, regardless of which method
was used in the significance evaluation, i.e., simulated genotype
data or the adjusted Lander and Kruglyak threshold after
accounting for multiple phenotypes. More severe CPT or WCST
deficits were indeed found in the families of the nested subset than
those in the remaining families, as summarized in Figure 1.
The distributions of the genome-wide LOD scores of the nested
OSAs that were based on age at onset and CPT false alarm rates
over 22 autosomal chromosomes are illustrated in Figure 3. The
corresponding chromosome-wide LOD distributions on chromo-
some 2 from the results of OSA and nested OSA are shown in
Figure 4. Compared with the initial linkage analysis for
schizophrenia using all available families, OSA using age at
earlier onset as covariate did strengthen and narrow the linkage
peak. Moreover, the strengthening pattern was further augmented
when additionally incorporating undegraded or degrade CPT false
alarm rate as another family covariate in the nested OSA.
Discussion
This study found that subsets of families of patients with
schizophrenia characterized by younger age at onset or neuro-
cognitive deficits exhibited increased linkage signals and reached
genome-wide significance on 2q22.1, which was nearby a
suggestive locus (a LOD score of 1.16 on 2q14.1) in the initial
genome-wide scan for the whole sample [21]. Furthermore, a
subset with greater CPT deficit nested within the families with
younger age at onset increased the linkage signal on 2q22.1 to a
LOD score as high as 7.71. The results have provided intriguing
clues for gene search for a complex disease as schizophrenia.
Table 1. Distribution of age at onset, CPT scores, and WCST scores in affected siblings.
Raw scores Adjusted z scores
a
Variables Mean (SD) Q1
b Q3
c Mean (SD) Q1
b Q3
c
Age at onset (N = 1,085) 22.6 (6.3) 18.0 26.0 --- --- ---
CPT-‘1-9’ indices
Undegraded (N = 917)
Hit rate 0.7 (0.3) 0.5 0.9 21.9 (2.0)
* 23.9 20.2
False alarm rate 0.1 (0.1) 0.0 0.1 1.5 (2.0)
* 3.0 20.1
d’ 2.6 (1.5) 1.6 3.7 22.3 (1.8)
* 23.9 20.9
Reaction time (centi-sec) 45.1 (11.2) 37.0 51.0 1.0 (1.4)
* 0.1 1.8
Degraded (N = 881)
Hit rate 0.4 (0.4) 0.0 0.8 22.5 (1.8)
* 24.2 20.8
False alarm rate 0.1 (0.1) 0.0 0.1 1.2 (1.8)
* 20.2 2.2
d’ 1.5 (1.6) 0.0 2.8 22.6 (1.5)
* 23.9 21.4
Reaction time (centi-sec) 53.6 (12.8) 45.0 66.0 1.0 (1.6)
* 0.0 2.5
WCST indices (N = 718)
Total Errors 73.4 (24.3) 55.0 95.0 1.4 (1.2)
* 0.6 2.3
Non-perseverative Errors 29.2 (25.2) 11.0 38.0 0.5 (1.9)
* 21.0 1.2
Perseverative Errors 44.3 (28.4) 19.0 72.0 1.4 (1.8)
* 20.2 3.1
Perseverative Response 54.7 (39.3) 20.0 93.0 1.4 (1.9)
* 20.3 3.2
Categories Achieved 1.9 (2.5) 0.0 3.0 21.0 (0.8)
* 21.6 20.7
Conceptual Level Response 26.1 (24.1) 4.7 43.0 21.3 (1.1)
* 22.2 20.7
Failure to Maintain Set 0.8 (1.3) 0.0 1.0 20.5 (1.0)
* 21.1 20.2
Trials to Complete First Category 74.3 (54.2) 13.0 129.0 1.0 (1.5)
* 20.6 2.4
aThe adjusted z scores were derived by means of standardizing the raw scores with adjustments for sex, age, and education against our norm data.
bCut-off at the lowest 25% of data.
cCut-off at the lowest 75% of data.
*P,0.0001 for the t-test examining if the adjusted z scores significantly different than 0.
doi:10.1371/journal.pone.0024103.t001
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scores are shown here).
Change in LOD
Maximum subset-
based
Mean family Covariates value
(SE)
Covariates
Cytogenetic
location Markers
(permutation
p value)
a
Initial
LOD
LOD (genome-wide
empirical p value)
b
No. Families
used/total (%)
c
Within
subset
Remaining
families
Age at onset 2q22.1 D2S442 3.3 (0.007) 0.87 4.17 (0.001) 295/556 (53.1) 18.70 (0.16)
** 26.86 (0.26)
CPT-‘1-9’ indices
Undegraded
Hit rate 8q13.1 D8S1136 2.25 (0.02) 0.95 3.20 (0.01) 160/509 (31.4) 24.06 (0.08)
** 20.97 (0.06)
False alarm rate 7q32.3 D7S1804 1.80 (0.01) 1.25 3.05 (0.01) 95/509 (18.7) 1.87 (0.13)
* 1.37 (0.07)
d9 8q13.1 D8S1136 0.95 (0.05) 1.83 2.78 (0.02) 158/509 (31.0) 24.20 (0.06)
** 21.54 (0.07)
Reaction time 9q34 D9S2157 0.43 (0.01) 3.00 3.43 (0.02) 49/509 (9.6) 3.46 (1.00)
** 0.81 (1.18)
Degraded
Reaction time 7q32.3 D7S1804 1.35 (0.004) 2.30 3.65 (0.01) 161/499 (32.3) 2.46 (0.86)
** 0.34 (1.39)
WCST indices
Non-perseverative
Errors
8q21.1 D8S1119 3.31 (0.004) 0.01 3.32 (0.01) 86/444 (19.4) 3.33 (0.13)
** 20.15 (0.06)
Categories
Achieved
8q13.1 D8S1136 0.51 (0.05) 1.79 2.30 (0.07) 151/444 (34.0) 21.63 (0.01)
** 20.70 (0.04)
aFamilies were randomly permuted for 1000 times with respect to the covariate ranking and a chromosome-wide p value for each chromosome was yielded.
bSignificance level derived from simulations; a genome-wide empirical P-value ,0.0029 [i.e., 0.05/(17 covariates)] is denoted in boldface as reaching genome-wide
significance.
cThe number of total families varied due to missing information on the covariate; subsets consisting of $ 15% of total families were reported here.
*P,0.001, **P,0.0001, for the mixed effect model comparing the families covariate values between the subset of families and the remaining one.
doi:10.1371/journal.pone.0024103.t002
Table 3. Nested ordered-subset analysis in the subgroup with early-onset schizophrenia by CPT or WCST.
Change in
LOD
Maximum subset-
based
Mean family covariate
value (SE)
Covariates
Cytogenetic
location Markers
(permutation
p value)
a
Initial
LOD
LOD (genome-wide
empirical p value)
b
No. Families
used/total (%)
Within nested
subset
Remaining
families
CPT-‘1-9’ indices
Undegraded hit rate 2q22.1 D2S442 0.23 (0.54) 4.23 4.46 275/282 (97.5) --- ---
Undegraded false alarm rate 2q22.1 D2S442 3.13 (0.004) 4.23 7.36 (,0.001) 228/282 (80.9) 1.84 (0.09)
* -0.04 (0.03)
Undegraded d9 2q22.1 D2S442 0.85 (0.08) 4.23 5.08 206/282 (73.0) --- ---
Undegraded reaction time 2q22.1 D2S442 0.48 (0.38) 4.23 4.71 268/282 (95.0) --- ---
Degraded hit rate 2q22.1 D2S442 0.70 (0.16) 4.23 4.93 242/281 (86.1) --- ---
Degraded false alarm rate 2q22.1 D2S442 3.48 (0.001) 4.23 7.71 (,0.001) 243/281 (86.5) 1.49 (0.09)
* -0.26 (0.04)
Degraded d9 2q22.1 D2S442 1.06 (0.09) 4.23 5.29 251/281 (89.3) --- ---
Degraded reaction time 2q22.1 D2S442 1.13 (0.07) 4.23 5.36 262/281 (93.2) --- ---
WCST indices
Total Errors 2q14.1 D2S410 0.53 (0.08) 3.84 4.37 67/263 (25.5) --- ---
Non-perseverative Errors 2q22.1 D2S442 0.68 (0.16) 3.64 4.32 247/263 (93.9) --- ---
Perseverative Errors 2q22.1 D2S442 0.00 (1.00) 3.64 4.17 263/263 (100.0) --- ---
Perseverative Response 2q22.1 D2S442 0.00 (1.00) 3.84 3.84 263/263 (100.0) --- ---
Categories Achieved 2q14.1 D2S410 0.56 (0.34) 3.18 3.74 55/263 (20.9) --- ---
Conceptual Level Response 2q14.1 D2S410 0.41 (0.40) 3.18 3.59 72/263 (27.4) --- ---
Failure to Maintain Set 2q22.1 D2S442 0.69 (0.47) 3.64 3.87 255/263 (97.0) --- ---
Trials to Complete First Category 2q22.1 D2S442 0.76 (0.15) 3.64 4.40 53/263 (20.2) --- ---
aFamilies were randomly permuted for 1000 times with respect to the covariate ranking and a chromosome-wide p value for each chromosome was yielded.
bSignificance level derived from simulations; a genome-wide empirical p-value ,0.0015 [i.e., 0.05/33 covariates)] is denoted in boldface as reaching genome-wide
significance.
*P,0.0001 for the mixed effect model comparing the families covariate values between the nested subset of families and the remaining ones.
doi:10.1371/journal.pone.0024103.t003
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PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e24103Our nested OSA approach demonstrates an exploratory way to
incorporate various schizophrenia-related characteristics in deci-
phering the genetic linkage signal to schizophrenia for families
with tied covariates (i.e., the same mean values of age at onset).
Our results revealed that in the onset-based subset of families
having maximal linkage signals, families with tied covariates might
in fact have linkage scores in the opposite directions. Accordingly,
a further subsetting by one CPT or WCST index might partition
the families into more homogeneous subsets and then result in
more increase in the LOD scores. Unlike other statistical methods
for detecting linkage by dissecting heterogeneity, which require a
prior stratification of the data [34] and do not consider
quantitative trait information [35], the OSA approach takes
advantage of disease-related phenotype information and has been
successfully applied in other complex diseases [36,37].
An important feature of this study is that we used age at onset
and several facets of the CPT and WCST as covariates to
reduce phenotypic and genetic heterogeneity of schizophrenia.
These are important features as they clearly impact the outcome
and severity of the illness. In addition, cognitive deficit is a core
symptom for schizophrenia [38] and the endophenotypic nature
of this deficit, more so for CPT [10] than for WCST
performance [29], may help index underlying genetic liability
or vulnerability of the disease. Particularly, greatest increases in
LOD scores were obtained for the families of schizophrenia
patients with more CPT false alarm rates nested within the
families with younger age at onset. Our findings were consistent
with previous studies indicating that some genetic variants were
associated with both younger age at onset and more severe
cognitive deficits of schizophrenia [39]. Therefore, the combi-
nation of clinical and cognitive fe a t u r e su s e di nt h i ss t u d ym a y
aid the identification of susceptibility and modifying genes for
schizophrenia.
Unlike previous linkage studies for psychiatric disorders that
used selective indices of neurocognitive tasks, either as a composite
profile of neurocognitive performance [40,41] or part of
multivariate traits [42], this study used all available indices that
exhibited significant familial resemblance. Our approach might
avoid missing potentially important endophenotypes, such as CPT
reaction time [43] or CPT hit rate [44]. Although the
psychometric construction of the indices on the tests might be
inter-correlated, the cognitive deficits underlying individual indices
might be attributed to quite different psychopathologies. For
example, previous studies indicated that individual CPT or WCST
indices are differentially associated with different symptom
dimensions for schizophrenia [43,45,46] or schizotypy [26,47].
In addition, the brain dysfunctions underlying WCST persever-
ative errors might be different from those underlying nonperse-
verative errors [9,48,49,50].
However, our approach might suffer from the issue of multiple
testing. To fully address this, several strategies were used in this
study to help interpret the significance of the OSA results. First, we
used permutation tests to estimate the statistical significance of the
change in LOD score from the subsets, which controlled for
inflation in the false-positive rate induced by examining multiple
family subsets for a given covariate. Second, two simulation-based
strategies were applied to estimate the genome-wide significance
level of subset-based LOD scores, with one based on the simulated
genotype data of this sample and the other one based on adjusting
the Lander-Kruglyak threshold that was also obtained by
simulations. Such simulations can help control for the inflation
in the false-positive rate over multiple chromosomes and markers
Figure 3. Genome-wide nonparametric LOD scores of two indices attaining genome-wide significance in the nested OSA linkage
analyses over 22 autosomal chromosomes.
doi:10.1371/journal.pone.0024103.g003
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PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e24103since genome-wide significance was estimated by the proportion of
times that a particular LOD score was reached anywhere in the
simulated genome. Finally, we used a Bonferroni correction to
adjust for multiple trait-related covariates after empirical genome-
wide P values were derived from simulations. The current results
of particular subset-based NPL-Z scores attaining genome-wide
significance might be very conservative because a Bonferroni-type
correction of the P value was applied for the correlated indices
among the CPT or WCST. It should be pointed out that it is very
difficult to assess the statistical significance of our subset-based
linkage signals due to the complexity inherent in the many possible
sources of multiple testing. Accordingly, the results reported here
might be better treated as exploratory and independent replication
is warranted to reassure the robustness of the findings.
The most striking linkage signal found in this study was
obtained from a nested OSA on chromosome 2q22.1 (D2S4422 at
147.4 cM). Intriguingly, a rank-based meta-analysis showed
evidence of linkage in this region [51]. A recent genome-wide
association study also found several SNPs on 2q22.1 to be
associated with schizophrenia [52]. What this study adds is that
this locus was likely to be involved with not only younger age at
onset but also greater CPT deficit in false alarm rate in
schizophrenia. The region contains potential susceptibility genes
for schizophrenia, like HNMT (Histamine N-methyltransferase)
and NR4A2 (alias NURR1, nuclear receptor subfamily 4, group
A, member 2, an orphan nuclear receptor and putative
transcription factor for the dopamine transporter). Although
previous studies found that neither HNMT [53] nor NR4A 2
[54,55,56] were associated with schizophrenia, the negative
findings might be attributed to the lack of sub-grouping by
particular quantitative traits in these studies. Further fine-mapping
studies using SNP arrays or deep resequencing methods among
patients with early age at onset and CPT deficits may help identify
the common genetic variants or rare coding sequence variants that
are involved in the genetic susceptibility to this subtype of
schizophrenia.
Figure 4. The result of OSA linkage analysis in the subset of families defined by a variety of covariates, including earlier age at
onset, greater undegraded CPT false alarm rate nested within earlier age at onset, greater degraded CPT false alarm rate nested
within earlier age at onset, versus that of the original linkage analysis of the whole sample on chromosome 2.
doi:10.1371/journal.pone.0024103.g004
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e24103This study is limited in several aspects. First, our samples
consisted of adults with Han Chinese ancestry only, and hence the
results may not extrapolate to populations of other ethnicities
where allele frequencies may vary. Second, despite our use of
different strategies to deal with multiple testing, our linkage
findings may not rule out the possibilities of false positive or false
negative because genome-wide statistical significance of OSA-
derived subset results remains a difficult issue. Third, the age at
onset of schizophrenia in this study was determined mainly on the
initiation of first psychotic symptoms. Although the age at first
functional impairment may be closer to the true onset of the
disease, there is an overall agreement that the onset of the first
psychotic episode is a better marker for the onset of schizophrenia
because it has a higher specificity than negative or nonspecific
symptoms [57].
In summary, we obtained possible evidence of linkage on
chromosome 2q22.1 in families of schizophrenia patients with
more CPT false alarm rates nested within the families with
younger age at onset. Our results suggest the presence of etiologic
heterogeneity in schizophrenia and highlight the importance of
unraveling the complex genetics of schizophrenia by incorporating
genetically informative phenotypes.
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